BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 14676846)

  • 21. Inhibitors of SCF-Skp2/Cks1 E3 ligase block estrogen-induced growth stimulation and degradation of nuclear p27kip1: therapeutic potential for endometrial cancer.
    Pavlides SC; Huang KT; Reid DA; Wu L; Blank SV; Mittal K; Guo L; Rothenberg E; Rueda B; Cardozo T; Gold LI
    Endocrinology; 2013 Nov; 154(11):4030-45. PubMed ID: 24035998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1.
    Spruck C; Strohmaier H; Watson M; Smith AP; Ryan A; Krek TW; Reed SI
    Mol Cell; 2001 Mar; 7(3):639-50. PubMed ID: 11463388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TGF-beta mediated G1 arrest in a human melanoma cell line lacking p15INK4B: evidence for cooperation between p21Cip1/WAF1 and p27Kip1.
    Flørenes VA; Bhattacharya N; Bani MR; Ben-David Y; Kerbel RS; Slingerland JM
    Oncogene; 1996 Dec; 13(11):2447-57. PubMed ID: 8957087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vorinostat enhances protein stability of p27 and p21 through negative regulation of Skp2 and Cks1 in human breast cancer cells.
    Uehara N; Yoshizawa K; Tsubura A
    Oncol Rep; 2012 Jul; 28(1):105-10. PubMed ID: 22484732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-throughput screening AlphaScreen assay for identification of small-molecule inhibitors of ubiquitin E3 ligase SCFSkp2-Cks1.
    Ungermannova D; Lee J; Zhang G; Dallmann HG; McHenry CS; Liu X
    J Biomol Screen; 2013 Sep; 18(8):910-20. PubMed ID: 23589337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retinoic acid stabilizes p27Kip1 in EBV-immortalized lymphoblastoid B cell lines through enhanced proteasome-dependent degradation of the p45Skp2 and Cks1 proteins.
    Zancai P; Dal Col J; Piccinin S; Guidoboni M; Cariati R; Rizzo S; Boiocchi M; Maestro R; Dolcetti R
    Oncogene; 2005 Apr; 24(15):2483-94. PubMed ID: 15735731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estrogens down-regulate p27Kip1 in breast cancer cells through Skp2 and through nuclear export mediated by the ERK pathway.
    Foster JS; Fernando RI; Ishida N; Nakayama KI; Wimalasena J
    J Biol Chem; 2003 Oct; 278(42):41355-66. PubMed ID: 12904306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein destruction: adapting roles for Cks proteins.
    Harper JW
    Curr Biol; 2001 Jun; 11(11):R431-5. PubMed ID: 11516665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamin D inhibits G1 to S progression in LNCaP prostate cancer cells through p27Kip1 stabilization and Cdk2 mislocalization to the cytoplasm.
    Yang ES; Burnstein KL
    J Biol Chem; 2003 Nov; 278(47):46862-8. PubMed ID: 12954644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Troglitazone induces p27Kip1-associated cell-cycle arrest through down-regulating Skp2 in human hepatoma cells.
    Koga H; Harada M; Ohtsubo M; Shishido S; Kumemura H; Hanada S; Taniguchi E; Yamashita K; Kumashiro R; Ueno T; Sata M
    Hepatology; 2003 May; 37(5):1086-96. PubMed ID: 12717389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inactivation of p27Kip1 by the viral E1A oncoprotein in TGFbeta-treated cells.
    Mal A; Poon RY; Howe PH; Toyoshima H; Hunter T; Harter ML
    Nature; 1996 Mar; 380(6571):262-5. PubMed ID: 8637577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression.
    Rorke EA; Zhang D; Choo CK; Eckert RL; Jacobberger JW
    Exp Cell Res; 2000 Aug; 259(1):149-57. PubMed ID: 10942587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transforming growth factor beta-induced activation of cyclin E-cdk2 kinase and down-regulation of p27Kip1 in C3H 10T1/2 mouse fibroblasts.
    Ravitz MJ; Yan S; Herr KD; Wenner CE
    Cancer Res; 1995 Apr; 55(7):1413-6. PubMed ID: 7882344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cks1 is degraded via the ubiquitin-proteasome pathway in a cell cycle-dependent manner.
    Hattori T; Kitagawa K; Uchida C; Oda T; Kitagawa M
    Genes Cells; 2003 Nov; 8(11):889-96. PubMed ID: 14622140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Triggering ubiquitination of a CDK inhibitor at origins of DNA replication.
    Furstenthal L; Swanson C; Kaiser BK; Eldridge AG; Jackson PK
    Nat Cell Biol; 2001 Aug; 3(8):715-22. PubMed ID: 11483956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ectopic expression of Cdk6 circumvents transforming growth factor-beta mediated growth inhibition.
    Zhang F; Taipale M; Heiskanen A; Laiho M
    Oncogene; 2001 Sep; 20(41):5888-96. PubMed ID: 11593394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of neddylation and deneddylation of cullin1 in SCFSkp2 ubiquitin ligase by F-box protein and substrate.
    Bornstein G; Ganoth D; Hershko A
    Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11515-20. PubMed ID: 16861300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of the cell cycle at the G1-S transition by proteolysis of cyclin E and p27Kip1.
    Nakayama KI; Hatakeyama S; Nakayama K
    Biochem Biophys Res Commun; 2001 Apr; 282(4):853-60. PubMed ID: 11352628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein-protein interactions involved in the recognition of p27 by E3 ubiquitin ligase.
    Xu K; Belunis C; Chu W; Weber D; Podlaski F; Huang KS; Reed SI; Vassilev LT
    Biochem J; 2003 May; 371(Pt 3):957-64. PubMed ID: 12529174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The expression of the ubiquitin ligase subunit Cks1 in human breast cancer.
    Slotky M; Shapira M; Ben-Izhak O; Linn S; Futerman B; Tsalic M; Hershko DD
    Breast Cancer Res; 2005; 7(5):R737-44. PubMed ID: 16168119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.